RecruitingNCT06252142

Study for Wait and Watch Suitable in Rectal Cancer

Ambispective Observational Study for Locally Advanced Rectal Cancer Patients Suitable for Wait and Watch (ARROW)


Sponsor

Tata Memorial Centre

Enrollment

260 participants

Start Date

Apr 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

One of the standard treatment options offered to patients of locally advanced rectal cancer is neoadjuvant (treatment given before surgery) radiotherapy \& chemotherapy followed by surgery. In patients whose tumour has completely reduced after neoadjuvant treatment, the wait and watch strategy is also an option. This is another standard treatment option for patients of locally advanced rectal cancers. In this, the patient is monitored after treatment completion. In this study, investigators are only going to observe the patient's response to treatment, monitor their side-effects due to treatment and assess their quality of life using standardized quality of life questionnaires. No additional tests or hospital visits will be required as a part of this study. The patient will be followed up, as per standard follow-up protocol, for at least 2 years after the completion of their treatment.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study looks at a strategy called 'watch and wait' for rectal cancer patients who responded very well to initial treatment. Instead of immediately undergoing surgery (which can be life-changing), some patients can be closely monitored to see if the cancer stays away. This trial collects data on how well this approach works. **You may be eligible if...** - You are over 18 and have been diagnosed with locally advanced rectal cancer - Your cancer responded very well to initial chemo-radiation (TNT or LCRT) and you are being managed with a watch-and-wait approach - Your tumor is in the lower or middle part of the rectum (within 7 cm of the anal opening) - Your cancer is a specific type (adenocarcinoma, non-mucinous/non-signet cell) **You may NOT be eligible if...** - You have not undergone initial treatment aimed at watch-and-wait - Your tumor is a high-risk or spread-around-the-circumference type - You are enrolled in another active interventional rectal cancer trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Tata Memorial centre

Mumbai, Maharashtra, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06252142


Related Trials